https://jamanetwork.com/journals/jam...rticle/2766367
This study took some steps to remediate some of concerns persons had about the USC and Santa Clara studies, but with similar results. In places where ubiquitous PCR nasal/throat swab was done, such as Vo, Italy, or New Rochelle, NY, you also get much higher infection rates than you currently see (which are the result of testing the patients you suspect have the disease, as it only detects active infection). The implication is that a lot of people mounted a defense to this disease. The comment above about the difficulty of contact tracing all 367,000 persons with Covid-19 in L.A. would be very difficult.
You can multiply the population of Washington State (or the U.S., or wherever) by 4.65% to get the denominator. Divide the the total deaths in Washington (or the respective area) from Covid by this number. That is the death rate for total cases of Covid in that area, and you will get a much lower death rate than we currently have. I did this for AZ and it drops the death rate to 0.3%.
In this community seroprevalence study in Los Angeles County, the prevalence of antibodies to SARS-CoV-2 was 4.65%. The estimate implies that approximately 367 000 adults had SARS-CoV-2 antibodies, which is substantially greater than the 8430 cumulative number of confirmed infections in the county on April 10.3 Therefore, fatality rates based on confirmed cases may be higher than rates based on number of infections. In addition, contact tracing methods to limit the spread of infection will face considerable challenges.
You can multiply the population of Washington State (or the U.S., or wherever) by 4.65% to get the denominator. Divide the the total deaths in Washington (or the respective area) from Covid by this number. That is the death rate for total cases of Covid in that area, and you will get a much lower death rate than we currently have. I did this for AZ and it drops the death rate to 0.3%.
Comment